Volitionrx (VNRX) Cash from Operations Growth (5y) (2016 - 2025)
Volitionrx (VNRX) Cash from Operations Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Volitionrx | 91,023.89 | -1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.97% |
| Sep 30, 2025 | 4.20% |
| Jun 30, 2025 | -7.16% |
| Mar 31, 2025 | 2.18% |
| Dec 31, 2024 | -15.89% |
| Sep 30, 2024 | -7.70% |
| Jun 30, 2024 | -19.41% |
| Mar 31, 2024 | -17.97% |
| Dec 31, 2023 | 30.44% |
| Sep 30, 2023 | -12.78% |
| Jun 30, 2023 | -19.75% |
| Mar 31, 2023 | -20.05% |
| Dec 31, 2022 | -8.35% |
| Sep 30, 2022 | -19.29% |
| Jun 30, 2022 | -17.37% |
| Mar 31, 2022 | 27.37% |
| Dec 31, 2021 | -15.01% |
| Sep 30, 2021 | -18.19% |
| Jun 30, 2021 | -17.64% |
| Mar 31, 2021 | -23.32% |